NCT00416962View on ClinicalTrials.gov

Safety and Pharmacokinetic Effects of Oseltamivir Alone or in Combination With Amantadine

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 31, 2006

Study Completion Date

December 31, 2006

Conditions
Healthy
Interventions
DRUG

amantadine hydrochloride

DRUG

oseltamivir phosphate

Trial Locations (1)

07936-1080

Novartis Investigative Site, East Hanover

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
collaborator

Hoffmann-La Roche

INDUSTRY

lead

Novartis

INDUSTRY